ResearcherKyorin UniversityNo recent work listed
Hiroshi Kitamura
Matched on ORCID iD 0000-0002-1592-931X; OpenAlex author ID A5102943302. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 3
- The Prognostic Utility of a Geriatric Assessment for Patients with Pancreatic Cancer Receiving Gemcitabine-based Chemotherapy: A Prospective Observational Stud… Co-author DOI 10.2169/internalmedicine.9689-22↗
- Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refrac… Co-author DOI 10.1007/s00280-014-2665-8↗
- [Chemoradiotherapy for Locally Advanced Pancreatic Cancer]. Co-author PMID 26489544↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Fumio Nagashima · 3 shared papers, 2015–2023 · strength 0.35
- Paper The Prognostic Utility of a Geriatric Assessment for Patients with Pancreatic Cancer Receiving Gemcitabine-based Chemot… DOI 10.2169/internalmedicine.9689-22↗
- Paper [Chemoradiotherapy for Locally Advanced Pancreatic Cancer]. PMID 26489544↗
- Paper Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemothe… DOI 10.1007/s00280-014-2665-8↗
- Junji Furuse · 3 shared papers, 2015–2023 · strength 0.35
- Paper The Prognostic Utility of a Geriatric Assessment for Patients with Pancreatic Cancer Receiving Gemcitabine-based Chemot… DOI 10.2169/internalmedicine.9689-22↗
- Paper [Chemoradiotherapy for Locally Advanced Pancreatic Cancer]. PMID 26489544↗
- Paper Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemothe… DOI 10.1007/s00280-014-2665-8↗
- Junichi Nakazawa · 1 shared paper, 2023 · strength 0.24
- Daisuke Naruge · 2 shared papers, 2015 · strength 0.12
- Naohiro Okano · 2 shared papers, 2015 · strength 0.12
- Akiyoshi Kasuga · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.